We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
1.1
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
0.4
quarters
Avg Time Held Equity only
1.1
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Dentsply Sirona
XRAY
$1.7B
| $26.6M | 0.19% |
+2,297,378
| New | +$28.7M |
2026 Q1
0 quarters
|
|
177
Qiagen
QGEN
$9.33B
| $26.5M | 0.19% |
+661,857
| New | +$31.3M |
2026 Q1
0 quarters
|
|
178
Merit Medical Systems
MMSI
$5.35B
| $26.4M | 0.19% |
382,865
+317,830
| +489% | +$24.8M |
2025 Q3
2 quarters
|
|
179
Align Technology
ALGN
$10B
| $26.2M | 0.18% |
+152,706
| New | +$26.7M |
2026 Q1
0 quarters
|
|
180
PG&E
PCG
$39.6B
| $26M | 0.18% |
1,477,708
-3,272,338
| -69% | -$55.7M |
2024 Q4
5 quarters
|
|
181
Amer Sports
AS
$16.5B
| $25.8M | 0.18% |
+782,454
| New | +$28.6M |
2026 Q1
0 quarters
|
|
182
Tandem Diabetes Care
TNDM
$1.14B
| $25.5M | 0.18% |
1,330,742
-112,094
| -8% | -$2.44M |
2025 Q3
2 quarters
|
|
183
Voya Financial
VOYA
$8.59B
| $25.5M | 0.18% |
372,677
-351,574
| -49% | -$25.5M |
2025 Q2
3 quarters
|
|
184
PPG Industries
PPG
$23B
| $25.2M | 0.18% |
235,430
+205,004
| +674% | +$23.2M |
2025 Q4
1 quarter
|
|
185
California Resources
CRC
$4.76B
| $25.1M | 0.18% |
362,066
+355,467
| +5,387% | +$20.1M |
2025 Q4
1 quarter
|
|
186
SL Green Realty
SLG
$3.44B
| $24.9M | 0.18% |
675,153
-11,399
| -2% | -$475K |
2025 Q3
2 quarters
|
|
187
UDR
UDR
$10.9B
| $24.9M | 0.18% |
737,550
+122,456
| +20% | +$4.5M |
2025 Q3
2 quarters
|
|
188
Kohl's
KSS
$2.4B
| $24.6M | 0.17% |
+1,904,083
| New | +$32.1M |
2026 Q1
0 quarters
|
|
189
Aaon
AAON
$7B
| $24.2M | 0.17% |
291,896
+288,296
| +8,008% | +$26.2M |
2025 Q2
3 quarters
|
|
190
Comfort Systems
FIX
$57.8B
| $23.8M | 0.17% |
17,281
-48,427
| -74% | -$61.5M |
2024 Q4
5 quarters
|
|
191
Regeneron Pharmaceuticals
REGN
$78.1B
| $23.7M | 0.17% |
30,625
-10,784
| -26% | -$8.26M |
2025 Q2
3 quarters
|
|
192
Alignment Healthcare
ALHC
$1.69B
| $23.6M | 0.17% |
1,337,777
+717,567
| +116% | +$14.4M |
2025 Q2
3 quarters
|
|
193
AT&T
T
$154B
| $23.3M | 0.16% |
804,849
-763,392
| -49% | -$20.4M |
2025 Q1
4 quarters
|
|
194
BJs Wholesale Club
BJ
$12.6B
| $23.2M | 0.16% |
+236,026
| New | +$22.8M |
2026 Q1
0 quarters
|
|
195
Encompass Health
EHC
$12.3B
| $23M | 0.16% |
237,626
+226,130
| +1,967% | +$23.2M |
2024 Q4
5 quarters
|
|
196
Polaris
PII
$2.92B
| $22.5M | 0.16% |
413,216
+114,002
| +38% | +$7.14M |
2025 Q2
3 quarters
|
|
197
Verizon
VZ
$177B
| $22.5M | 0.16% |
+448,162
| New | +$20.8M |
2026 Q1
0 quarters
|
|
198
Avantor
AVTR
$10.5B
| $21.9M | 0.15% |
2,791,157
+207,151
| +8% | +$2.04M |
2025 Q4
1 quarter
|
|
199
Ameren
AEE
$28.5B
| $21.8M | 0.15% |
198,699
-93,687
| -32% | -$10M |
2025 Q4
1 quarter
|
|
200
Gentex
GNTX
$4.37B
| $21.7M | 0.15% |
991,846
+376,451
| +61% | +$8.73M |
2024 Q4
5 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.